Most people begin to see weight loss within four to eight weeks after reaching their target dose, which might take several weeks due to gradual dose increases
The medications are only a tool to help patients switch to a more healthy diet, he said
It usually subsides as the body adjusts to the medication
(B) Semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of uncoupling protein 1 (UCP1), mitochondrial biosynthesis, and thermogenic marker, or promote fatty browning through nitric oxide synthase (NOS), neuropeptides (NPs), sirtuin 1 (STRT1), signal transducer and activator of transcription 3 (STAT3), and bone morphogenetic protein 4 (BMP4) signaling
adults are obese and approximately 1 in 11 suffer from severe obesity
Front Cell Dev Biol 8:602574 Han X, Ding C, Zhang G, Pan R, Liu Y, Huang N, Hou N, Han F, Xu W, Sun X (2020) Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway